Form 8-K - Current report:
SEC Accession No. 0001193805-23-000963
Filing Date
2023-07-07
Accepted
2023-07-07 16:16:23
Documents
14
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e618763_8k-plx.htm   iXBRL 8-K 26381
2 AMENDMENT NO. 1 TO AMENDED AND RESTATED BYLAWS OF THE COMPANY e618763_ex3-1.htm EX-3.1 5142
  Complete submission text file 0001193805-23-000963.txt   232772

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE plxpq-20230630.xsd EX-101.SCH 2965
4 XBRL DEFINITION FILE plxpq-20230630_def.xml EX-101.DEF 26193
5 XBRL LABEL FILE plxpq-20230630_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE plxpq-20230630_pre.xml EX-101.PRE 22362
8 EXTRACTED XBRL INSTANCE DOCUMENT e618763_8k-plx_htm.xml XML 3600
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Winddown Corp. (Filer) CIK: 0001497504 (see all company filings)

EIN.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36351 | Film No.: 231076972
SIC: 2834 Pharmaceutical Preparations